1-10 of 10
Jingda Xu
Close
Sort by
Journal Articles

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma

Ondrej Havranek, Jingda Xu, Stefan Köhrer, Zhiqiang Wang, Lisa Becker, Justin M. Comer, Jared Henderson, Wencai Ma, John Man Chun Ma, Jason R. Westin, Dipanjan Ghosh, Nicholas Shinners, Luhong Sun, Allen F. Yi, Anusha R. Karri, Jan A. Burger, Tomasz Zal, R. Eric Davis
Journal: Blood
Blood (2017) 130 (8): 995–1006.
https://doi.org/10.1182/blood-2016-10-747303
Published: 2017
Includes: Multimedia, Supplemental data
Journal Articles

Molecular Aspects of Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma Provide Biomarkers and Targets for Specific Inhibition

Ondrej Havranek, MD PhD, Jingda Xu, PhD, Stefan Koehrer, MD, Zhiqiang Wang, PhD, Justin M Comer, Lisa Becker, Allen F Yi, Jan A. Burger, MD PhD, Jason R. Westin, MD, Tomasz Zal, PhD, Richard Eric Davis, MD
Journal: Blood
Blood (2016) 128 (22): 779.
https://doi.org/10.1182/blood.V128.22.779.779
Published: 2016
Journal Articles

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma: Tonic Alone in the Germinal Center B-Cell Subtype, Plus Self Antigen-Induced in the Activated B-Cell Subtype

Ondrej Havranek, MDPhD, Stefan Koehrer, MD, Jingda Xu, PhD, Lisa Becker, Justin M Comer, Anusha R Karri, Zhiqiang Wang, PhD, Wencai Ma, PhD, Jason R Westin, MD, Tomasz Zal, PhD, Jan A Burger, MD PhD, R Eric Davis, MD
Journal: Blood
Blood (2015) 126 (23): 464.
https://doi.org/10.1182/blood.V126.23.464.464
Published: 2015
Journal Articles

The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype

Ondrej Havranek, MDPhD, Stefan Koehrer, MD, Justin M Comer, Zhiqiang Wang, PhD, Jingda Xu, PhD, Dipanjan Ghosh, PhD, Nicholas Shinners, PhD, Luhong Sun, MD PhD, Wencai Ma, PhD, Jan A Burger, MDPhD, R Eric Davis, MD
Journal: Blood
Blood (2014) 124 (21): 493.
https://doi.org/10.1182/blood.V124.21.493.493
Published: 2014
Journal Articles

Selinexor (KPT-330) Is Not Cross-Resistant with Chemotherapy and Demonstrates Strong Synergy with Targeted Therapy in DLBCL

Jingda Xu, PhD, R Eric Davis, MD, Zhiqiang Wang, PhD, Jason R. Westin, MD
Journal: Blood
Blood (2014) 124 (21): 4503.
https://doi.org/10.1182/blood.V124.21.4503.4503
Published: 2014
Journal Articles

A critical role of autocrine sonic hedgehog signaling in human CD138 + myeloma cell survival and drug resistance

Zhiqiang Liu, Jingda Xu, Jin He, Yuhuan Zheng, Haiyan Li, Yong Lu, Jianfei Qian, Pei Lin, Donna M. Weber, Jing Yang, Qing Yi
Journal: Blood
Blood (2014) 124 (13): 2061–2071.
https://doi.org/10.1182/blood-2014-03-557298
Published: 2014
Includes: Supplemental data
Journal Articles

Activation Of Autophagy By Bone Marrow Adipocytes Protects Myeloma Cells From Chemotherapy-Induced Apoptosis

Jing Yang, PhD, Jingda Xu, PhD, Zhiqiang Liu, PhD, Jin He, Huan Liu, Pei Lin, MD, Robert Z. Orlowski, M.D., Ph.D, Larry W. Kwak, MD, PhD, Qing Yi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1915.
https://doi.org/10.1182/blood.V122.21.1915.1915
Published: 2013
Journal Articles

Anti-β2 Microglobulin Monoclonal Antibodies Overcome Bortezomib-Induced Drug Resistance In Multiple Myeloma By Inhibition Of Autophagy

Mingjun Zhang, PhD, Jin He, Yong Lu, PhD, Yuhuan Zheng, PhD, Bangxing Hong, MD, PhD, Haiyan Li, MD, PhD, Zhiqiang Liu, PhD, Jingda Xu, PhD, Huan Liu, Jianfei Qian, PhD, Qing Yi, MD, PhD, Jing Yang, PhD
Journal: Blood
Blood (2013) 122 (21): 929.
https://doi.org/10.1182/blood.V122.21.929.929
Published: 2013
Journal Articles

Myeloma Cells Exhibit Inhibitory Effect On Osteoclastogenesis

Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Haiyan Li, MD, PhD, Jingda Xu, PhD, Jin He, Eryong Huang, Yong Lu, PhD, Jungsun Park, Bangxing Hong, PhD, Mingjun Zhang, PhD, Jianfei Qian, PhD, Pei Lin, MD, Larry W. Kwak, MD, PhD, Qing Yi, MD, PhD, Jing Yang, PhD
Journal: Blood
Blood (2012) 120 (21): 439.
https://doi.org/10.1182/blood.V120.21.439.439
Published: 2012
Journal Articles

P38 MAPK Activity in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction in Vivo

Jin He, PhD, Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Jianfei Qian, PhD, Haiyan Li, MD, PhD, Yong Lu, PhD, Jingda Xu, PhD, Bangxing Hong, PhD, Mingjun Zhang, PhD, Pei Lin, MD, Zhen Cai, Robert Z. Orlowski, M.D., Ph.D., Larry W Kwak, MD, PhD, Qing Yi, MD, PhD, Jing Yang, PhD
Journal: Blood
Blood (2012) 120 (21): 566.
https://doi.org/10.1182/blood.V120.21.566.566
Published: 2012